Blincytorems.com

Visit blincytorems.com
  • 11 months ago

    Last scanned

  • 9 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

CD19-Positive B-Cell Precursor ALL Regimen | BLINCYTO® (blinatumomab)

Learn about BLINCYTO® (blinatumomab) treatment. See Full Safety Info, including Boxed Warning.

Blincytorems.com thumbnail
Blincytorems.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for blincytorems.com: 44.237.239.125, 52.42.189.45. Moreover, DNS used with this website include ns-1518.awsdns-61.org, ns-1844.awsdns-38.co.uk, ns-221.awsdns-27.com, ns-658.awsdns-18.net. Subnet identifier ranges from 44.224.0.0 to 44.255.255.255. Classless Inter-Domain Routing (CIDR) is 44.224.0.0/11. ARIN net type is Reallocated.

  • 11 months ago

    Last scanned

  • 9 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of blincytorems.com is MarkMonitor Inc. and the name expires on 2024-10-21. According to open source data, you can reach the owner at amgendomains@amgen.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.

  • precursor
  • all
  • regimen
  • B-Cell
  • risk evaluation and mitigation strategy
  • blincyto
  • CD19-Positive

Websites similar to blincytorems.com